SB
Spectrum Brands Holdings, Inc. (SPB)·Q4 2025 Earnings Summary
Executive Summary
- Q4 results: revenue $733.5M (-5.2% y/y; +4.8% q/q), gross margin 35.0% (-220 bps y/y), GAAP EPS $2.19 and adjusted EPS $2.61 . Versus consensus, revenue was modestly below ($738.6M est.) while adjusted EPS materially beat ($0.91 est.) as tax benefits and lower share count offset margin pressure (S&P Global)*.
- Segment mix: H&G returned to growth (+3.2% y/y) aided by late-season demand; GPC modestly down (-1.5%) with better margins; HPC declined double digits (-11.9%) on U.S./EMEA softness and supply constraints .
- Guidance reinstated: FY26 framework calls for flat to low single-digit net sales growth, low single-digit adjusted EBITDA growth, and ~50% adjusted FCF conversion; capex $50–60M, cash taxes $40–50M, D&A $115–125M, corporate costs ~$66M (vs $54M FY25) .
- Balance sheet/capital returns: Ended Q4 with net leverage 1.58x, cash $123.6M, liquidity $615.9M; repurchased ~4.4M shares ($326M) in FY25 and another ~0.4M post year-end ($21.5M). Quarterly dividend of $0.47 declared Nov 11 .
What Went Well and What Went Wrong
-
What Went Well
- Adjusted EPS delivered a sizable beat vs consensus ($2.61 vs $0.91 est.) on a one-time tax benefit, lower shares, and disciplined OpEx control despite gross margin pressure (S&P Global; management attribution) .*
- H&G grew 3.2% y/y as late-season demand supported Controls; innovation (Spectracide Wasp/Hornet/Yellowjacket Trap; Hot Shot Flying Insect Trap) outperformed and is set for broader FY26 distribution .
- GPC margin expanded 200 bps (16.6% vs 14.6%) on cost savings and pricing; Nature’s Miracle, Good Boy, and Aquatics distribution gains supported mix .
- Management quote: “We believe that the worst of the tariff and economic disruptions…are now behind us…GPC and H&G [are] to return to growth in 2026.” .
-
What Went Wrong
- Revenue declined 5.2% y/y; gross margin fell 220 bps on lower volume, mix, inflation, and tariffs; HPC revenue -11.9% y/y and margin -30 bps on U.S./EMEA softness and prior supply constraints .
- Adjusted EBITDA fell 8% y/y to $63.4M; adjusted EBITDA margin -30 bps to 8.6% .
- Supply interruptions from earlier pause of China-sourced imports continued to impact fill rates in GPC/HPC into Q4; U.S./EMEA demand in HPC remained soft .
Financial Results
Overall performance vs prior periods and estimates
Versus S&P Global consensus (Q4 FY25)
Values retrieved from S&P Global.*
Segment breakdown (Q4 FY25)
Select balance sheet/FCF KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO (strategy/positioning): “We believe that the worst of the tariff and economic disruptions…are now behind us…Our adjusted free cash flow of $171 million…beat our own expectations…we are…positioned…to be the consolidator of choice within the pet and home and garden industries.” .
- CEO (HPC): “We are hell-bent on improving the profitability…[and] excited to work towards a strategic solution…once again.” .
- CFO (drivers of Q4): “Adjusted diluted EPS increased to $2.61, driven by a one-time tax benefit… and the reduction in shares outstanding, partially offset by lower adjusted EBITDA.” .
- CFO (FY26 framework): “Adjusted EBITDA is expected to grow low single digits…Tariffs are expected to be largely offset…Corporate costs ~ $66M…Capex $50–60M; cash taxes $40–50M; D&A $115–125M.” .
Q&A Highlights
- HPC options: Management reiterated unwillingness to discuss live M&A but confirmed intent to revisit strategic options as tariff volatility subsides; industry fragmentation could create opportunities .
- Pet business trajectory: Shelf resets and distribution gains; improved POS; expect GPC to return to growth first; vision to grow Pet to $3B revenue and $500M EBITDA over time .
- Pricing/elasticity: Less retail price taken than feared; largest increases in appliances; SPB “took its medicine” early—expects relative benefit as competitors price up .
- ERP and carve-out: Expanding S/4HANA to HPC improves efficiency and carve-out readiness without delaying strategic options .
- Tariff mitigation: Gross exposure cut materially; remaining impacts addressed via supplier concessions, cost actions, and pricing .
Estimates Context
- Q4 FY25 comparisons vs S&P Global: Revenue $733.5M vs $738.6M est. (-0.7%); adjusted/primary EPS $2.61 vs $0.91 est. (+186%); 6 and 8 estimates respectively (S&P Global).* The EPS beat was driven by a one-time tax benefit, lower share count from buybacks, and lower OpEx, partially offset by weaker gross margin . Values retrieved from S&P Global.*
Key Takeaways for Investors
- EPS beat despite revenue softness signals strong tactical execution (tax planning, buybacks, OpEx control) amid persistent tariff/mix pressures; however, the beat’s quality is tempered by one-time tax benefits .
- Reinstated FY26 framework (flat-to-LSD sales; LSD EBITDA growth; ~50% FCF conversion) resets expectations and should reduce uncertainty; Q1 FY26 flagged as the most challenged quarter .
- H&G momentum plus GPC stabilization underpin FY26 growth; HPC remains a drag near term as U.S. SKU rationalization and supply chain simplification proceed .
- Tariff risk now “largely mitigated” with diversified sourcing and pricing; remaining volatility remains a watch item but less acute than mid-year .
- Balance sheet flexibility (1.58x net leverage) supports continued buybacks and selective M&A in Pet/H&G to compound growth and mix shift to consumables .
- Trading implication: Expect near-term sentiment support from a large EPS beat and guidance reinstatement; watch for sell-side upward revisions to FY26 EPS/FCF tied to lower corporate costs and margin stabilization (S&P Global baseline updated in Q4).*
- Medium term: Execution on HPC profitability and any strategic outcome is a key re-rating lever; Pet accretive M&A and continued innovation in H&G could expand margins and reduce cyclicality .
Other Relevant Press Releases During Q4 Window
- Quarterly dividend: $0.47 per share payable Dec 9, 2025; record date Nov 24, 2025 .
Footnote: Values retrieved from S&P Global.*